S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
NASDAQ:YGYI

Youngevity International (YGYI) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.0111
$0.0111
50-Day Range
$0.29
$0.39
52-Week Range
$0.24
$2.74
Volume
N/A
Average Volume
N/A
Market Capitalization
$450,660.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
YGYI stock logo

About Youngevity International Stock (NASDAQ:YGYI)

Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers cannabidiol oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network. Youngevity International, Inc. also markets its products through a range of consumer Websites, such as youngevity.com; ygyi.com; heritagemakers.com; hempfx.com; clrroasters.com; cafelarica.com; javalution.com. The company was formerly known as AL International, Inc. and changed its name to Youngevity International, Inc. in July 2013. Youngevity International, Inc. was founded in 1996 and is headquartered in Chula Vista, California.

YGYI Stock News Headlines

Youngevity International Inc YGYI
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
YGYI - Youngevity International, Inc.
Youngevity International Inc PR (YGYIP)
The #1 Opportunity of the decade?
It's no wonder the Department of Defense is heavily invested in this technology. And why The Pentagon is pouring $20 billion into it.
Youngevity International Inc Pref Share YGYIP
Youngevity International, Inc. to Host Shareholder Call
Youngevity International, Inc. (YGYIP)
See More Headlines
Receive YGYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Youngevity International and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/16/2019
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Catalog & mail - order houses
Sub-Industry
N/A
Current Symbol
NASDAQ:YGYI
Employees
469
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
18,028,000
Market Cap
$450,660.00
Optionable
Not Optionable
Beta
3.73
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Stephan Wallach (Age 54)
    Chairman & CEO
    Comp: $434.44k
  • Mr. David Stephen Briskie (Age 60)
    Pres, Chief Investment Officer & Director
    Comp: $434.44k
  • Mr. William G. Thompson (Age 60)
    Chief Financial Officer
  • Ms. Michelle G. Wallach (Age 50)
    Chief Operating Officer
    Comp: $214.58k
  • Dr. Joel D. Wallach
    Co-Founder, Member of the Scientific Advisory Board & Member of Athletic Advisory Board
  • Dr. Ma Lan M.D.
    MS, Co-Founder & Member of the Scientific Advisory Board
  • Mr. Brad Kenson (Age 62)
    Chief Technology Officer
  • Ms. Jonnie Taylor
    Sr. Exec. VP of Customer Service
  • Mr. Raffy Lorentzian (Age 65)
    VP & Controller
  • Dwayne Dundore
    Pres of Khrysos

YGYI Stock Analysis - Frequently Asked Questions

How were Youngevity International's earnings last quarter?

Youngevity International, Inc. (NASDAQ:YGYI) posted its quarterly earnings results on Tuesday, April, 16th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.06) by $0.40. The company had revenue of $36.11 million for the quarter.

What other stocks do shareholders of Youngevity International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Youngevity International investors own include NewAge (NBEV), Allena Pharmaceuticals (ALNA), TherapeuticsMD (TXMD), Energy Transfer (ET), FuelCell Energy (FCEL), Frontier Communications (FTR), Heat Biologics (HTBX), Neptune Wellness Solutions (NEPT) and Rapid7 (RPD).

This page (NASDAQ:YGYI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners